spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Celsion 

 HSMN NewsFeed - 23 Feb 2015
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jul 2014
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Feb 2014
Celsion Announces FDA Clearance of the OPTIMA Study - A Pivotal Phase III Trial of ThermoDox in Primary Liver Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 14 Oct 2013
Gregory L. Weaver Joins Atossa Genetics' Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 23 Apr 2013
Celsion Corporation Provides Business Update
Biopharmaceuticals Devices Drug Delivery Oncology
 HSMN NewsFeed - 25 Aug 2011
Celsion Announces the Appointment of Gary Renshaw, D.O., as Executive Medical Director
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 12 Jul 2011
Celsion Announces Management and Board Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Mar 2011
Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Feb 2011
Data Monitoring Committee Unanimously Recommends Continuation of Celsion's Phase III ThermoDox(R) HEAT Study to Treat Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Oct 2010
Celsion Receives Positive FDA Guidance for its New Drug Application for ThermoDox(R) to Treat Primary Liver Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Aug 2010
Celsion Receives Fast Track Designation for ThermoDox(R) Development Program to Treat Primary Liver Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 9 Mar 2010
Medifocus, Inc. Announces That It Has Received Approval to Initiate Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer from the Food and Drug Administration (FDA), Investigational Device Exemption (IDE) Application
Devices Oncology FDA
 HSMN NewsFeed - 10 Feb 2010
Data Monitoring Committee Recommends Continuation of Celsion's Phase III ThermoDox(R) Study for Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jan 2010
Celsion Announces CFO Departure
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 3 Jun 2009
Celsion Receives Final $15 Million Payment from Boston Scientific for Prolieve Assets Completing its Transition to a Drug Development Company
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Mar 2009
Celsion Receives Orphan Drug Designation for ThermoDox to Treat Primary Liver Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Feb 2009
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2008
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jun 2008
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2008
Celsion Commences Global Phase III Study for Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Feb 2008
Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2007
Celsion Bolsters Clinical Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2007
CELSION Announces the Departure of Chief Financial Officer
Biopharmaceuticals Devices Drug Delivery Personnel
 HSMN NewsFeed - 21 Jun 2007
Celsion Completes Sale of Prolieve Assets
Devices Acquisitions Urology
 HSMN NewsFeed - 21 Jun 2007
Boston Scientific Purchases Prostate Treatment Technology from Celsion Corporation
Devices Acquisitions Urology
 HSMN NewsFeed - 18 Apr 2007
Celsion Announces Boston Scientific Exercises Its Option to Purchase Prolieve(R) Assets
Devices Urology Acquisitions
 HSMN NewsFeed - 14 Mar 2007
Celsion Expands Board, Appoints New Independent Director
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 8 Feb 2007
Celsion and AMS Settle Patent Dispute
Devices Licensing Litigation
 HSMN NewsFeed - 8 Feb 2007
American Medical Systems Announces Settlement with Celsion Corporation
Devices Licensing Litigation
 HSMN NewsFeed - 21 Dec 2006
Celsion Corporation Announces New President/CEO
Devices Urology Personnel
 HSMN NewsFeed - 29 Sep 2006
Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 7 Sep 2006
Celsion Announces Management Changes and Formation of Prolieve and Oncology Divisions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2006
Forest Laboratories Inc. Announces Appointment of Dr. Lawrence S. Olanoff as President and Chief Operating Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 27

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 27 additional stories matching:
Celsion
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.